Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF

Blood

Volumn 126, Issue 11, 2015, Pages e19-e29

  Huffman, Jennifer E ^a,b,c   De Vries, Paul S ^d   Morrison, Alanna C ^e   Sabater Lleal, Maria ^f   Kacprowski, Tim ^g   Auer, Paul L ^h   Brody, Jennifer A ⁱ   Chasman, Daniel I ^j,k   Chen, Ming Huei ^l   Guo, Xiuqing ^m   Lin, Li An ^e,n   Marioni, Riccardo E ^a,o   Müller Nurasyid, Martina ^p,q,r   Yanek, Lisa R ^s   Pankratz, Nathan ^t   Grove, Megan L ^e   De Maat, Moniek P M ^d   Cushman, Mary ^u   Wiggins, Kerri L ⁱ   Qi, Lihong ^v   Sennblad, Bengt ^f   Harris, Sarah E ^a   Polasek, Ozren ^w   Riess, Helene ^p,x   Rivadeneira, Fernando ^d   Rose, Lynda M ^j   Goel, Anuj ^y   Taylor, Kent D ^m   Teumer, Alexander ^g   Uitterlinden, André G ^d   Vaidya, Dhananjay ^s,z   Yao, Jie ^m   Tang, Weihong ^aa   Levy, Daniel ^b,c   Waldenberger, Melanie ^p,r   Becker, Diane M ^s,z   Folsom, Aaron R ^aa   Giulianini, Franco ^j   Greinacher, Andreas ^g   Hofman, Albert ^d   Huang, Chiang Ching ^h   Kooperberg, Charles ^ab   Silveira, Angela ^f   Starr, John M ^a   Strauch, Konstantin ^p,q   Strawbridge, Rona J ^f   Wright, Alan F ^a   McKnight, Barbara ^ac   Franco, Oscar H ^d   Zakai, Neil ^u   Mathias, Rasika A ^s   Psaty, Bruce M ^i,ac,ad   Ridker, Paul M ^j,k   Tofler, Geoffrey H ^ae   Völker, Uwe ^g   Watkins, Hugh ^y   Fornage, Myriam ^e,n   Hamsten, Anders ^f   Deary, Ian J ^a   Boerwinkle, Eric ^e,af   Koenig, Wolfgang ^x,ag   Rotter, Jerome I ^m   Hayward, Caroline ^a   Dehghan, Abbas ^d   Reiner, Alex P ^ab,ac   O'Donnell, Christopher J ^b   Smith, Nicholas L ^ac,ad,ah   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^h UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m HARBOR UCLA MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^o UNIVERSITY OF QUEENSLAND   (Australia)

^p INSTITUTE OF EPIDEMIOLOGY   (Germany)

^q UNIVERSITY OF MUNICH   (Germany)

^r DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^s JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^u UNIVERSITY OF VERMONT   (United States)

^v UNIVERSITY OF CALIFORNIA   (United States)

^w UNIVERSITY OF SPLIT   (Croatia)

^x UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

^y UNIVERSITY OF OXFORD   (United Kingdom)

^z JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^aa UNIVERSITY OF MINNESOTA   (United States)

^ab Fred Hutchinson Cancer Research Center   (United States)

^ac UNIVERSITY OF WASHINGTON   (United States)

^ad CENTER FOR HEALTH STUDIES   (United States)

^ae UNIVERSITY OF SYDNEY   (Australia)

^af BAYLOR COLLEGE OF MEDICINE   (United States)

^ag TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ah Veterans Affairs Office of Research and Development   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; VON WILLEBRAND FACTOR; KCNT1 PROTEIN, HUMAN; NERVE PROTEIN; POTASSIUM CHANNEL;

ANCESTRY GROUP; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EXOME; FUNCTIONAL GENOMICS; GENE FREQUENCY; GENE HID1; GENE KATNB1; GENE KCNT1; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEMOSTASIS; HERITABILITY; HUMAN; MARKER GENE; PRIORITY JOURNAL; COHORT ANALYSIS; GENETIC ASSOCIATION STUDY; GENETIC VARIATION; GENETICS; META ANALYSIS; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

COHORT STUDIES; FACTOR VII; FACTOR VIII; FIBRINOGEN; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS; VON WILLEBRAND FACTOR;

EID: 84942364202     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-02-624551     Document Type: Article

References (71)

1. Folsom AR. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost. 2001;86(1):366-373.
2. Folsom AR, Cushman M, Heckbert SR, Ohira T, Rasmussen-Torvik L, Tsai MY. Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism. J Thromb Haemost. 2007;5(8):1674-1678.
3. Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation. 2005;112(20):3080-3087.
4. Danesh J, Lewington S, Thompson SG, et al; Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294(14):1799-1809.
5. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345(8943):152-155.
6. Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117(11):1449-1459.
7. Danik JS, Paré G, Chasman DI, et al. Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study. Circ Cardiovasc Genet. 2009;2(2):134-141.
8. Lovely RS, Yang Q, Massaro JM, et al. Assessment of genetic determinants of the association of γ′ fibrinogen in relation to cardiovascular disease. Arterioscler Thromb Vasc Biol. 2011;31(10):2345-2352.
9. Sabater-Lleal M, Huang J, Chasman D, et al; VTE Consortium; STROKE Consortium; Wellcome Trust Case Control Consortium 2 (WTCCC2); C4D Consortium; CARDIoGRAM Consortium. Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation. 2013;128(12):1310-1324.
10. Wassel CL, Lange LA, Keating BJ, et al. Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe). Blood. 2011;117(1):268-275.
11. Johnsen JM, Auer PL, Morrison AC, et al; NHLBI Exome Sequencing Project. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Blood. 2013;122(4):590-597.
12. Taylor KC, Lange LA, Zabaneh D, et al. A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium. Hum Mol Genet. 2011;20(17):3525-3534.
13. Smith NL, Chen MH, Dehghan A, et al; Wellcome Trust Case Control Consortium. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121(12):1382-1392.
14. Dehghan A, Yang Q, Peters A, et al; Wellcome Trust Case Control Consortium. Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet. 2009;2(2):125-133.
15. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-753.
16. Psaty BM, O'Donnell CJ, Gudnason V, et al; CHARGE Consortium. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(1):73-80.
17. Grove ML, Yu B, Cochran BJ, et al. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One. 2013;8(7):e68095.
18. Peloso GM, Auer PL, Bis JC, et al; NHLBI GO Exome Sequencing Project. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet. 2014;94(2):223-232.
19. Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34(9):E2393-E2402.
20. Liu X, Jian X, Boerwinkle E. dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat. 2011;32(8):894-899.
21. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet. 2011;89(1):82-93.
22. Li B, Leal SM. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet. 2008;83(3):311-321.
23. Morris AP, Zeggini E. An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol. 2010;34(2):188-193.
24. Dong C, Wei P, Jian X, et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015;24(8):2125-2137.
25. Jian X, Boerwinkle E, Liu X. In silico prediction of splice-altering single nucleotide variants in the human genome. Nucleic Acids Res. 2014;42(22):13534-13544.
26. Ivaskevicius V, Jusciute E, Steffens M, et al. gammaAla82Gly represents a common fibrinogen gamma-chain variant in Caucasians. Blood Coagul Fibrinolysis. 2005;16(3):205-208.
27. Brennan SO, Fellowes AP, Faed JM, George PM. Hypofibrinogenemia in an individual with 2 coding (gamma82 A→G and Bbeta235 P→L) and 2 noncoding mutations. Blood. 2000;95(5):1709-1713.
28. Wyatt J, Brennan SO, May S, George PM. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala→Gly and an intron two GT→AT splice site mutation. Thromb Haemost. 2000;84(3):449-452.
29. Tang W, Cushman M, Green D, et al. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans. Am J Hematol. 2015;90(6):534-540.
30. Maghzal GJ, Brennan SO, George PM. Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans. Thromb Haemost. 2003;90(6):1021-1028.
31. Schmelzer CH, Ebert RF, Bell WR. A polymorphism at B beta 448 of fibrinogen identified during structural studies of fibrinogen Baltimore II. Thromb Res. 1988;52(2):173-177.
32. Chaing S, Clarke B, Sridhara S, et al. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor. Blood. 1994;83(12):3524-3535.
33. Herrmann FH, Wulff K, Auerswald G, et al; Greifswald Factor FVII Deficiency Study Group. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia. 2009;15(1):267-280.
34. Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood. 2007;109(1):112-121.
35. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood. 2007;109(1):145-154.
36. Corrales I, Catarino S, Ayats J, et al. High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods. Haematologica. 2012;97(7):1003-1007.
37. Schneppenheim R, Brassard J, Krey S, et al. Defective dimerization of von Willebrand factor subunits due to a Cys→Arg mutation in type IID von Willebrand disease. Proc Natl Acad Sci USA. 1996;93(8):3581-3586.
38. Eikenboom JC, Reitsma PH, Peerlinck KM, Briët E. Recessive inheritance of von Willebrand's disease type I. Lancet. 1993;341(8851):982-986.
39. Mazurier C. von Willebrand disease masquerading as haemophilia A. Thromb Haemost. 1992;67(4):391-396.
40. Peerlinck K, Eikenboom JC, Ploos Van Amstel HK, et al. A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J Haematol. 1992;80(3):358-363.
41. Gaucher C, Jorieux S, Mercier B, Oufkir D, Mazurier C. The "Normandy" variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene. Blood. 1991;77(9):1937-1941.
42. Kroner PA, Friedman KD, Fahs SA, Scott JP, Montgomery RR. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem. 1991;266(29):19146-19149.
43. Cacheris PM, Nichols WC, Ginsburg D. Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem. 1991;266(21):13499-13502.
44. Viel KR, Machiah DK, Warren DM, et al. A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood. 2007;109(9):3713-3724.
45. Scanavini D, Legnani C, Lunghi B, Mingozzi F, Palareti G, Bernardi F. The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels. Thromb Haemost. 2005;93(3):453-456.
46. MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508(7497):469-476.
47. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-423.
48. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38(2):209-213.
49. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687-702.
50. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105-1116.
51. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
52. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study. Design and preliminary data. Prev Med. 1975;4(4):518-525.
53. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J III. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33-50.
54. Vaidya D, Yanek LR, Moy TF, Pearson TA, Becker LC, Becker DM. Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. Am J Cardiol. 2007;100(9):1410-1415.
55. Holle R, Happich M, Löwel H, Wichmann HE; MONICA/KORA Study Group. KORA-a research platform for population based health research. Gesundheitswesen. 2005;67(Suppl 1):S19-S25.
56. Wichmann HE, Gieger C, Illig T; MONICA/KORA Study Group. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67(Suppl 1):S26-S30.
57. Zemunik T, Boban M, Lauc G, et al. Genome-wide association study of biochemical traits in Korcula Island, Croatia. Croat Med J. 2009;50(1):23-33.
58. Deary IJ, Gow AJ, Pattie A, Starr JM. Cohort profile: the Lothian Birth Cohorts of 1921 and 1936. Int J Epidemiol. 2012;41(6):1576-1584.
59. Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC. The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol. 2004;86(1):130-147.
60. Deary IJ, Gow AJ, Taylor MD, et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 2007;7:28.
61. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871-881.
62. Clarke R, Peden JF, Hopewell JC, et al; PROCARDIS Consortium. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361(26):2518-2528.
63. Hofman A, Breteler MM, van Duijn CM, et al. The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol. 2009;24(9):553-572.
64. Hofman A, Darwish Murad S, van Duijn CM, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28(11):889-926.
65. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403-422.
66. Samnegård A, Silveira A, Lundman P, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med. 2005;258(5):411-419.
67. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307.
68. Ridker PM, Chasman DI, Zee RY, et al; Women's Genome Health Study Working Group. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem. 2008;54(2):249-255.
69. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19(1):61-109.
70. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43(3):246-252.
71. Hays J, Hunt JR, Hubbell FA, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13(9 Suppl):S18-S77.